Director at GeoVax Labs (NASDAQ: GOVX) granted 6,000 options

Rhea-AI Filing Summary

GeoVax Labs director Nicole Lemerond received a grant of 6,000 stock options for GeoVax Labs, Inc. common stock. These options were awarded at an exercise price of $1.18 per share and are scheduled to expire on June 17, 2036. Following this grant, she holds 6,000 derivative securities directly, reflecting a routine equity compensation award rather than an open-market purchase or sale.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Lemerond Nicole

Role null

Type	Security	Shares	Price	Value
Grant/Award	Stock Option	6,000	$0.00	--

Holdings After Transaction: Stock Option — 6,000 shares (Direct, null)

Footnotes (1)

Key Figures

Stock options granted: 6,000 options Exercise price: $1.18 per share Expiration date: June 17, 2036 +1 more

4 metrics

Stock options granted 6,000 options Grant to director Nicole Lemerond

Exercise price $1.18 per share Strike price for granted options

Expiration date June 17, 2036 Option term end

Derivative holdings after transaction 6,000 options Total derivative securities following grant

Key Terms

Stock Option, exercise price, expiration date, Common Stock, +1 more

5 terms

Stock Option financial

"security_title: "Stock Option" with underlying Common Stock"

A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.

exercise price financial

"conversion_or_exercise_price: "1.1800" per underlying share"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

expiration date financial

"expiration_date: "2036-06-17T00:00:00.000Z" for the option grant"

The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.

Common Stock financial

"underlying_security_title: "Common Stock" for the option"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Form 4 regulatory

"INSIDER FILING DATA (Form 4) for GeoVax Labs, Inc."

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Lemerond Nicole

(Last) (First) (Middle)

C/O GEOVAX LABS, INC.

1955 LAKE PARK DR, SUITE 300

(Street)

SMYRNA GEORGIA 30080

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
GeoVax Labs, Inc. [ GOVX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/17/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option	$1.18	06/17/2026		A		6,000		06/17/2027	06/17/2036	Common Stock	6,000	$0	6,000	D

Explanation of Responses:

	/s/ Nicole Lemerond	06/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did GeoVax (GOVX) report for Nicole Lemerond?

GeoVax reported that director Nicole Lemerond received 6,000 stock options. These options give her the right to buy common shares at a fixed price, representing a routine equity compensation grant rather than an open-market trade.

What is the exercise price of Nicole Lemerond’s GeoVax (GOVX) stock options?

The stock options were granted with an exercise price of $1.18 per share. This means she can purchase GeoVax common stock at $1.18, regardless of the market price, any time before the options expire.

When do Nicole Lemerond’s GeoVax (GOVX) stock options expire?

The stock options are scheduled to expire on June 17, 2036. After this expiration date, any unexercised options will lapse, and she will no longer have the right to buy shares under this specific grant.

How many GeoVax (GOVX) derivative securities does Nicole Lemerond hold after this grant?

After the grant, she holds 6,000 derivative securities linked to GeoVax common stock. These represent stock options, not currently owned shares, and must be exercised at the $1.18 price to convert into common stock.

Was there any open-market buying or selling in this GeoVax (GOVX) Form 4?

No, the Form 4 shows a grant of 6,000 stock options as compensation. It does not report any open-market purchases or sales of GeoVax common stock by Nicole Lemerond in this transaction.